Article
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
Cancer - 1 Apr 2011
Small Brent J, Rawson Kerri Sharp, Walsh Erin, Jim Heather S L, Hughes Tiffany F, Iser Lindsay, Andrykowski Michael A, Jacobsen Paul B
Abstract excerpt
BACKGROUND: Recent attention has focused on the negative effects of chemotherapy on the cognitive performance of cancer survivors. The current study examined modification of this risk by catechol-O-methyltransferase (COMT) genotype based on evidence in adult populations that the presence of a Val allele is associated with poorer cognitive performance. METHODS: Breast cancer survivors treated with radiotherapy (n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
